Browse studies
Find your next paid study
4 recruiting studies matching your filters
Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Lebrikizumab/ LY3650150 in Adult Participants With Perennial Allergic Rhinitis
The main purpose of this study is to evaluate the efficacy and safety of lebrikizumab in adult participants with perennial allergic rhinitis. Participants can…
Perennial Allergic Rhinitis (PAR)
Estimated
~$10 – $7,500
Eli Lilly and CompanyNCT06339008
Phase 2
Epigenetic Mechanism Reprogramming Mucosal Anti-viral Immunity in Allergic Asthma VIRAL MUCOSAL REPROGRAMMING
This is a mechanistic, controlled, open-label, single-site study to evaluate the effects of RG-RV16 inoculation on airway mucosal gene expression and airway re…
AsthmaAllergic RhinitisCat Allergy+1 more
Estimated
~$10 – $6,250
The University of Texas Medical Branch, GalvestonNCT05331170
A Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-up
Background: Allergic or sinus diseases can affect the skin, sinuses, airways, and other parts of the body. Examples include pollen and environmental allergies…
Allergy, Sinus Disorders, Atopic Diseases, Asthma, Allergic Rhinitis, Atopic Dermatitis, EoE, Drug a
Estimated
~$10 – $675
National Institute of Allergy and Infectious Diseases (NIAID)NCT06732414
Observational
Does the Addition of Batten Grafting Improve Nasal Outcomes in Patients Undergoing Septoplasty and Turbinate Reduction? A Pragmatic Randomized Controlled Trial
The objective of this study is to compare the effectiveness of batten grafts plus septoplasty and turbinate reduction (intervention arm) compared to septoplast…
Nasal ObstructionSeptal DefectAllergic Rhinitis+2 more
Estimated
~$10 – $7,500
Northwell HealthNCT05287841